1-2 of 2
David S Millan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

AUTX703, a Novel and Potent KAT2A and KAT2B Protein Degrader, Induces Differentiation and Offers Survival Advantage in a Primary Human AML Xenograft Model

Hélène Duparc, James Neef, Janany Kandiah, Maulasri Bhatta, Agathe Chédeville, Joe DeBartolo, Sara Sinicropi-Yao, Betty Chan, Alex Constan, Christophe Marzac, Jean-Baptiste Micol, Laura Antipov, Stephane De Botton, Katharine E Yen, David S Millan, Iléana Antony-Debré, Kimberly S Straley
Journal: Blood
Blood (2024) 144 (Supplement 1): 3585.
https://doi.org/10.1182/blood-2024-208179
Published: 2024
Journal Articles

FT-1101: A Structurally Distinct Pan-BET Bromodomain Inhibitor with Activity in Preclinical Models of Hematologic Malignancies

David S Millan, PhD, Monica A Alvarez Morales, MS, Kenneth J Barr, PhD, Daniel Cardillo, MS, Alan Collis, PhD, Christopher J Dinsmore, PhD, Jaime A Escobedo, PhD, Kevin P Foley, PhD, Torsten Herbertz, PhD, Stephen Hubbs, BS, Goss S Kauffman, BS, Katherine J Kayser-Bricker, PhD, Mark T Kershaw, MSc, George P Luke, PhD, Matthew W Martin, PhD, Crystal McKinnon, BS, Rachel L Mendes, MS, Kristina R Muskiewicz, MA, Shawn ER Schiller, MS, Patricia Soulard, MS, Adam C Talbot, PhD, Duncan Walker, PhD, Lili Yao, MS, Grace L Williams, PhD
Journal: Blood
Blood (2015) 126 (23): 1367.
https://doi.org/10.1182/blood.V126.23.1367.1367
Published: 2015